Cytokinetics Inc. buy Raymond James
Start price
28.12.23
/
50%
€76.00
Target price
28.12.24
€83.06
Performance (%)
-26.97%
Price
16.05.24
€55.50
Summary
This prediction is currently active. The price of Cytokinetics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -26.97%. This prediction currently runs until 28.12.24. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cytokinetics Inc. | -6.723% | -6.723% |
iShares Core DAX® | -0.051% | 4.829% |
iShares Nasdaq 100 | 1.659% | 2.417% |
iShares Nikkei 225® | 0.658% | -2.173% |
iShares S&P 500 | 0.964% | 2.547% |
Comments by Raymond_James for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target raised by analysts at Raymond James from $63.00 to $92.00. They now have an "outperform" rating on the stock.
Ratings data for CYTK provided by MarketBeat